Effect of Community ART Groups on retention-in-care among patients on ART in Tete Province, Mozambique: a cohort study

Tom Decroo, Barbara Telfer, Carla Das Dores, Richard A White, Natacha Dos Santos, Alec Mkwamba, Sergio Dezembro, Mariano Joffrisse, Tom Ellman, Carol Metcalf, Tom Decroo, Barbara Telfer, Carla Das Dores, Richard A White, Natacha Dos Santos, Alec Mkwamba, Sergio Dezembro, Mariano Joffrisse, Tom Ellman, Carol Metcalf

Abstract

Objectives: Estimate the effect of participation in Community ART Groups (CAG) versus individual care on retention-in-care (RIC) on antiretroviral therapy (ART).

Design: Retrospective cohort study.

Setting: High levels of attrition (death or loss-to-follow-up (LTFU) combined) on ART indicate that delivery models need to adapt in sub-Saharan Africa. In 2008, patients more than 6 months on ART began forming CAG, and took turns to collect ART refills at the health facility, in Tete Province, Mozambique,.

Participants: 2406 adult patients, retained in care for at least 6 months after starting ART, during the study period (date of CAG introduction at the health facility-30 April 2012).

Methods: Data up to 30 April 2012 were collected from patient records at eight health facilities. Survival analysis was used to compare RIC among patients in CAG and patients in individual care, with joining a CAG treated as an irreversible time-dependent variable. Multivariable Cox regression was used to estimate the effect of CAG on RIC, adjusted for age, sex and health facility type and stratified by calendar cohort.

Results: 12-month and 24-monthRIC from the time of eligibility were, respectively, 89.5% and 82.3% among patients in individual care and 99.1% and 97.5% among those in CAGs (p<0.0001). CAG members had a greater than fivefold reduction in risk of dying or being LTFU (adjusted HR: 0.18, 95% CI 0.11 to 0.29).

Conclusions: Among patients on ART, RIC was substantially better among those in CAGs than those in individual care. This study confirms that patient-driven ART distribution through CAGs results in higher RIC among patients who are stable on ART.

Keywords: HIV; community participation; health services accessibility; peer support; treatment outcome.

Conflict of interest statement

Competing interests: None declared.

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Figures

Figure 1
Figure 1
Study flow diagram: inclusion of patients on ART in the study.(Uploaded separately). ART, antiretroviral therapy; CAG, Community ART groups.
Figure 2
Figure 2
Retention-in-care by CAG status among 2406 patients on ART, between 2008 and 2012, in Tete, Mozambique. (Uploaded separately). ART, antiretroviral therapy; CAG, Community ART Group.

References

    1. UNAIDS. Fact sheet 2016. 2016: UNAIDS; .
    1. UNAIDS. 90-90-90: an ambitious treatment target to help end the AIDS epidemic. Switzerland, Geneva: UNAIDS, 2014. .
    1. World Health Organization. Supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. recommendations for a public health approach: World Health Organization, 2014. .
    1. Fox MP, Rosen S. Retention of adult patients on antiretroviral therapy in low- and Middle-Income countries: systematic review and meta-analysis 2008-2013. J Acquir Immune Defic Syndr 2015;69:98–108. 10.1097/QAI.0000000000000553
    1. Govindasamy D, Ford N, Kranzer K. Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review. AIDS 2012;26:2059–67. 10.1097/QAD.0b013e3283578b9b
    1. Kredo T, Ford N, Adeniyi FB, et al. . Decentralising HIV treatment in lower- and middle-income countries. Cochrane Database Syst Rev 2013;6:CD009987 10.1002/14651858.CD009987.pub2
    1. Callaghan M, Ford N, Schneider H. A systematic review of task- shifting for HIV treatment and care in Africa. Hum Resour Health 2010;8:8:8 10.1186/1478-4491-8-8
    1. Duncombe C, Rosenblum S, Hellmann N, et al. . Reframing HIV care: putting people at the centre of antiretroviral delivery. Trop Med Int Health 2015;20:430–47. 10.1111/tmi.12460
    1. Lambdin BH, Micek MA, Sherr K, et al. . Integration of HIV care and treatment in primary health care centers and patient retention in central Mozambique: a retrospective cohort study. J Acquir Immune Defic Syndr 2013;62:e146–e152. 10.1097/QAI.0b013e3182840d4e
    1. Wandeler G, Keiser O, Pfeiffer K, et al. . Outcomes of antiretroviral treatment programs in rural Southern Africa. J Acquir Immune Defic Syndr 2012;59:e9–e16. 10.1097/QAI.0b013e31823edb6a
    1. Caluwaerts C, Maendaenda R, Maldonado F, et al. . Risk factors and true outcomes for lost to follow-up individuals in an antiretroviral treatment programme in Tete, Mozambique. Int Health 2009;1:97–101. 10.1016/j.inhe.2009.03.002
    1. Posse M, Baltussen R. Barriers to access to antiretroviral treatment in Mozambique, as perceived by patients and health workers in urban and rural settings. AIDS Patient Care STDS 2009;23:867–75. 10.1089/apc.2009.0050
    1. Kober K, Van Damme W. Expert patients and AIDS care. A literature review on expert patient programmes in high-income countries, and an exploration of their relevance for HIV/AIDS care in low-income countries with severe human resource shortages. 2008. .
    1. Bemelmans M, Baert S, Goemaere E, et al. . Community-supported models of care for people on HIV treatment in sub-Saharan Africa. Trop Med Int Health 2014;19:968–77. 10.1111/tmi.12332
    1. Rasschaert F, Telfer B, Lessitala F, et al. . A qualitative assessment of a community antiretroviral therapy group model in Tete, Mozambique. PLoS One 2014;9:e91544 10.1371/journal.pone.0091544
    1. Decroo T, Telfer B, Biot M, et al. . Distribution of antiretroviral treatment through self-forming groups of patients in Tete Province, Mozambique. J Acquir Immune Defic Syndr 2011;56:e39–e44. 10.1097/QAI.0b013e3182055138
    1. Decroo T, Koole O, Remartinez D, et al. . Four-year retention and risk factors for attrition among members of community ART groups in Tete, Mozambique. Trop Med Int Health 2014;19:514–21. 10.1111/tmi.12278
    1. World Health Organization. WHO Country Cooperation Strategy 2009-2013. Mozambique: World Health Organization; 2009. .
    1. UNAIDS. AIDSinfo: UNAIDS, 2016. Available at .
    1. Ministry of Health Mozambique. Global AIDS Response Progress Report for the Period 2010 - 2011, Mozambique: Ministry of Health Mozambique, 2012. .
    1. Decroo T, Panunzi I, das Dores C, et al. . Lessons learned during down referral of antiretroviral treatment in Tete, Mozambique. J Int AIDS Soc 2009;12:6 10.1186/1758-2652-12-6
    1. Lawn SD, Harries AD, Anglaret X, et al. . Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2008;22:1897–908. 10.1097/QAD.0b013e32830007cd
    1. Gupta A, Nadkarni G, Yang WT, et al. . Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis. PLoS One 2011;6:e28691 10.1371/journal.pone.0028691
    1. Jobarteh K, Shiraishi RW, Malimane I, et al. . Community ART support groups in Mozambique: the potential of patients as partners in Care. PLoS One 2016;11:e0166444 10.1371/journal.pone.0166444
    1. Vandendyck M, Motsamai M, Mubanga M, et al. . Community-based ART resulted in excellent retention and can leverage community empowerment in rural Lesotho: a mixed method study. HIV/AIDS Research and Treatment - Open Journal 2015;2:44–50. 10.17140/HARTOJ-2-107
    1. Wandeler G, Keiser O, Pfeiffer K, et al. . Outcomes of antiretroviral treatment programs in rural Southern Africa. J Acquir Immune Defic Syndr 2012;59:e9–e16. 10.1097/QAI.0b013e31823edb6a
    1. Langebeek N, Gisolf EH, Reiss P, et al. . Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis. BMC Med 2014;12:142 10.1186/s12916-014-0142-1
    1. Bateganya MH, Amanyeiwe U, Roxo U, et al. . Impact of support groups for people living with HIV on clinical outcomes: a systematic review of the literature. J Acquir Immune Defic Syndr 2015;68(S3):S36874.
    1. Rasschaert F, Decroo T, Remartinez D, et al. . Sustainability of a community-based anti-retroviral care delivery model—a qualitative research study in Tete, Mozambique. J Int AIDS Soc 2014;17:18910 10.7448/IAS.17.1.18910
    1. Wouters E, Van Damme W, van Rensburg D, et al. . Impact of baseline health and community support on antiretroviral treatment outcomes in HIV patients in South Africa. AIDS 2008;22:2545–8. 10.1097/QAD.0b013e32831c5562
    1. Zachariah R, Teck R, Buhendwa L, et al. . How can the community contribute in the fight against HIV/AIDS and tuberculosis? An example from a rural district in Malawi. Trans R Soc Trop Med Hyg 2006;100:167–75. 10.1016/j.trstmh.2005.07.008
    1. Weidle PJ, Wamai N, Solberg P, et al. . Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda. Lancet 2006;368:1587–94. 10.1016/S0140-6736(06)69118-6
    1. Jaffar S, Amuron B, Foster S, et al. . Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet 2009;374:2080–9. 10.1016/S0140-6736(09)61674-3
    1. Wools-Kaloustian KK, Sidle JE, Selke HM, et al. . A model for extending antiretroviral care beyond the rural health centre. J Int AIDS Soc 2009;12:22 10.1186/1758-2652-12-22
    1. Grimsrud A, Bygrave H, Doherty M, et al. . Reimagining HIV service delivery: the role of differentiated care from prevention to suppression. J Int AIDS Soc 2016;19:21484 10.7448/IAS.19.1.21484
    1. Phillips A, Shroufi A, Vojnov L, et al. . Sustainable HIV treatment in Africa through viral-load-informed differentiated care. Nature 2015;528:S68–S76. 10.1038/nature16046
    1. World Health Organization. Factsheet. HIV treatment and care.What’s new in service delivery? World Health Organization, 2015. .

Source: PubMed

3
Tilaa